Clinical Implications for the Use of a Biomarker for Subclinical Rejection - A Disconnection Between the Premise and the Conclusion

American Journal of Transplantation - United Kingdom
doi 10.1111/ajt.15327
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Development and Clinical Validity of a Novel Blood-Based Molecular Biomarker for Sub-Clinical Acute Rejection Following Kidney Transplant

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

Conclusion: Lessons for the Dialogue Between Theory and Data

2007English

The Disconnection Between Tumor Response and Survival

Nature Clinical Practice Oncology
2007English

An Opportunity to Bridge the Gap Between Clinical Research and Clinical Practice: Implications for Clinical Training.

Psychotherapy
PsychiatryClinical PsychologyMental Health
2012English

The Use of FoxP3 as a Biomarker and Prognostic Factor for Malignant Human Tumors

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2007English

Cost-Effectiveness of a Blood-Based Biomarker Compared to Endomyocardial Biopsy for the Diagnosis of Acute Allograft Rejection

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2016English

Evaluation of a Portable Monitor (Watch-Pat100) and Implications for Clinical Guidelines for the Use of Portable Monitors in Diagnosing OSAS

The Open Otorhinolaryngology Journal
2012English

Implications and Conclusion

2020English

The MethDet: A Technology for Biomarker Development

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy